Overview

Oral Colchicine in Men With Castrate Resistant Prostate Cancer

Status:
Withdrawn
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the prostate specific antigen response to continuous low dose oral colchicine.
Phase:
Phase 2
Details
Lead Sponsor:
Milton S. Hershey Medical Center
Treatments:
Colchicine